Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Immunoglobulin G4-Related Disease
- Baricitinib Plus Glucocorticoid for Eosinophilia in IgG4-RD
- Study of Sirolimus in IgG4-related Disease
- A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease
- Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)
- Belimumab Treatment for IgG4-related Disease
- Zanubrutinib in Patients With IgG4-Related Disease
- A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease
- Open Label Two-Arm Study to Evaluate Rilzabrutinib (PRN1008) in IgG4-Related Disease Patients
- Characterizing IgG4-RD With 68Ga-FAPI PET/CT
- Withdraw Drug in Stable IgG4-Related Disease
- Safety and Efficacy of Abatacept in IgG4-Related Disease
- To Evaluate the Clinical Efficacy of Iguratimod in the Treatment of IgG4 Related Disease (IgG4-RD) With Mild Symptom
- Treatment of IgG4-Related Disease With Revlimid and Rituximab
- Leflunomide for Maintenance of Remission in IgG4 Related Disease
- Study of Treatment Response on IgG4 Related Disease (IgG4RD)
- Glucocorticoids in Patients With IgG4-RD
- 18F-FDG PET/CT for IgG4-Related Disease